Global Equity Strategy: Health Care Hitting On All Cylinders - Overweight
Global equities remain in a short-term consolidation phase, however we continue to believe the longer-term trend is up and to the right for the...
393 Views
Para IV Winners and Losers - October 2018
This month’s Para IV developments suggest that there can be benefit for Amneal Pharmaceuticals Inc (AMRX US) in Xyren and Faslodex, Wockhardt Ltd...
436 Views
Year-End Resolution Seen for Akorn/Fresenius Case
A post-trial briefing schedule for the Akorn/Fresenius case was set July 16 that would suggest a final legal resolution of the case around...
285 Views
Global Strategy: Health Care Outperforming - Overweight; India Breaking Out -Add Exposure
Today's report puts a spotlight on the Health Care Sector, which is assuming a global leadership role vs. other Sectors. We also focus on...
540 Views
NxStage/Fresenius FTC Review Could Be Helped by Recent CVS Announcement
On April 4, CVS Health announced a new initiative focused on chronic kidney disease with a planned introduction of “a truly innovative new home...
158 Views